Effectiveness of a Vaccination Program in the Community ObGyn Setting
Project Number5U01IP000190-02
Contact PI/Project LeaderSWAMY, GEETA K.
Awardee OrganizationDUKE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant):
Although most adults realize the significance of immunizations for infant and child health, many do not recognize that vaccines offer a safe, cost-effective way to prevent morbidity and mortality among adolescents and adults. Nearly 45,000 US adults die each year from vaccine preventable diseases. The Institute of Medicine has called for the development of innovative strategies to improve vaccine coverage among adolescents and adults. Obstetrician-Gynecologists (Ob/Gyns) are uniquely positioned to immunize women of all ages against vaccine-preventable diseases. They are often the first point of contact for young women seeking care for reproductive health. Ob/Gyns function as primary care physicians, providing ? of all medical visits to women aged 17- 21 years. However, many Ob/Gyns do not routinely assess immunization status or administer vaccines in their offices. Commonly noted obstacles to providing vaccinations include cost/inadequate reimbursement, beliefs about their role in primary care, inadequate vaccine handling capability, lack of vaccine information, and safety/liability concerns in pregnancy. Our primary objective is to conduct a clinic-based study to develop and assess the effectiveness of a vaccination program for adolescent and adult women in the community Ob/Gyn setting. We propose to evaluate 4 Ob/Gyn offices in the Raleigh-Durham, NC area through in-depth, structured interviews of Ob/Gyn providers and office staff. In addition to details on current vaccine practices, medical record documentation, and encounter coding reimbursement, personnel will be queried on attitudes about vaccination, perceived barriers to an Ob/Gyn-based program, and ideas on overcoming such barriers. Findings will be used to design a program for adolescent and adult women, tailored for implementation in 2 of the 4 Ob/Gyn offices. Limited to vaccines for human papillomavirus and influenza & pertussis in pregnancy/postpartum, the program will cover a 12-month period, including 1 influenza season. Effectiveness of the intervention will be determined by pre- and post-program vaccination rates, program satisfaction, and willingness to continue the program. Detailed recording of all development and implementation strategies will allow for direct and immediate quantification of the resources and financial support required for vaccine program development and performance.
Public Health Relevance Statement
PUBLIC HEALTH STATEMENT
This study has the potential to improve the capacity of the health care system to effectively
deliver vaccines to adolescent and adult women. If successful, Ob/Gyns may tailor and
implement the vaccination program in their offices, ultimately serving as a major force in the
reduction of vaccine-preventable diseases in the US.
National Center for Immunization and Respiratory Diseases
CFDA Code
185
DUNS Number
044387793
UEI
TP7EK8DZV6N5
Project Start Date
01-September-2008
Project End Date
31-August-2011
Budget Start Date
01-September-2009
Budget End Date
31-August-2011
Project Funding Information for 2009
Total Funding
$225,000
Direct Costs
$144,231
Indirect Costs
$80,769
Year
Funding IC
FY Total Cost by IC
2009
National Center for Immunization and Respiratory Diseases
$225,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01IP000190-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01IP000190-02
Patents
No Patents information available for 5U01IP000190-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01IP000190-02
Clinical Studies
No Clinical Studies information available for 5U01IP000190-02
News and More
Related News Releases
No news release information available for 5U01IP000190-02
History
No Historical information available for 5U01IP000190-02
Similar Projects
No Similar Projects information available for 5U01IP000190-02